Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

US Patent 8871250 · Granted Oct 28, 2014

Estimated economic value: $2,512,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mucinous glycoprotein (MUC-1) vaccine2015
Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine2015
Vaccine for modulating between T1 and T2 immune responses2013
Vaccine for modulating between T1 and T2 immune responses2012
Methods of detecting T-cell activation2003
Lipid-modified muc-1 derivatives2003
Enhancement of the cellular immune response2003
Enhancement of the cellular immune response2003
Enhancement of the cellular immune response2001
Methods of detecting T-cell activation and treating disorders associated with T-2000
Enhancement of the cellular immune response1998
Lectin-antibody immunoassays for TF epitope-bearing antigens1993